Brief: Rubius Therapeutics Posts Q3 Loss Per Share Of $0.55
08/11/2021 22:45
Nov 8 (Reuters) - Rubius Therapeutics Inc RUBY.O :
* RUBIUS THERAPEUTICS REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
* Q3 LOSS PER SHARE $0.55
* Q3 EARNINGS PER SHARE VIEW $-0.57 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX1nllbC
Further company coverage: RUBY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rubius Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Apple, TCR2 Therapeutics, Silvergate Capital
Brief: Rubius Therapeutics Inc - Nasdaq Notified Co That Trading In Co's Stock Will Be Suspended Upon Opening Of Business On March 7, 2023
Brief: Rubius Therapeutics Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company
Rubius Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Baidu, Boeing, Microsoft